Cromos Pharma
Vlad Bogin, MD, FACP has held various leadership positions throughout their career. Vlad is currently the CEO of Nobilis Therapeutics, a position they have held since January 2016. Prior to that, they were the CEO and Founder of Cromos Pharma, a contract research organization specializing in biopharmaceutical clinical outsourcing. Vlad started this role in August 2006, and it is ongoing. Additionally, they served as the Chairman of the Board of Directors and President of Medistem Inc from September 2010 to March 2014, leading the company through various milestones including clinical trials and a successful sale. In 2008, they held a role as a Director at Boehringer Ingelheim. Overall, Vlad Bogin has extensive experience in the biotech and pharmaceutical industries, with a focus on clinical research and leadership.
Vlad Bogin, MD, FACP, began their education journey in 1991 when they joined Yale University School of Medicine as a medical student. Vlad pursued their studies there for two years, until 1993, focusing on medicine as their field of study. Following this, from 1997 to 2001, Vlad Bogin attended the University of Rochester School of Medicine and Dentistry. During this period, they held the position of Resident and Chief Medical Resident, although the specific field of study is not indicated.
Cromos Pharma
1 followers
Cromos Pharma is a US-based, international contract research organization delivering fully integrated clinical research solutions, in all trial phases, across a wide range of therapeutic indications. Our expert team, comprised of 95% MDs, has extensive expertise in study design, medical writing, regulatory affairs, site management, patient recruitment and data management. Cromos Pharma has experience in delivering success in a wide range of trial types, from biosimilars and generics, to successfully managing trials of novel therapeutics in a wide range of clinical indications. Our team provides full-service solutions to international pharma and biotech companies in high-recruiting regions, assuring exceptional data quality. Cromos Pharma combines global expertise with in-depth experience and knowledge in the US, Central and Eastern Europe, Central Asia, Republic of Georgia, and Türkiye resulting in rapid patient recruitment. Our team has met or reduced enrollment timelines in 95% of conducted trials. We provide accelerated study start-up timelines in our regions of operation. Regulatory inspections by FDA and EMA and site audits attest to the highest quality of our clinical data. Established in 2004, Cromos Pharma has strong regional experience that is supported by a global network of offices. Its international HQ is in Portland, Oregon, USA and its European HQ is in Dublin, Ireland.